Company · CIK 2102720

# Tarsier Pharma Ltd.

| CIK | [2102720](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002102720) (SEC EDGAR) |
| --- | --- |
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | L3 |
| Listed | TARX |
| First annual or quarterly report | none on EDGAR |

## Offerings

 1 registration

| Registration | Label and status | First filed | Last event | Filings |
| --- | --- | --- | --- | --- |
| 333-295210 | First-time registration Amended | 2026-04-21 | 2026-07-16 | 6 |

## Filings

 7

| Filed | Filing | Registration | Accession |
| --- | --- | --- | --- |
| 2026-07-16 | [F-1/A](https://www.sec.gov/Archives/edgar/data/2102720/000121390026078792/0001213900-26-078792-index.htm) Amendment | 333-295210 | 0001213900-26-078792 |
| 2026-07-15 | [F-1/A](https://www.sec.gov/Archives/edgar/data/2102720/000121390026078039/0001213900-26-078039-index.htm) Amendment | 333-295210 | 0001213900-26-078039 |
| 2026-06-16 | [F-1/A](https://www.sec.gov/Archives/edgar/data/2102720/000121390026069143/0001213900-26-069143-index.htm) Amendment | 333-295210 | 0001213900-26-069143 |
| 2026-06-08 | [F-1/A](https://www.sec.gov/Archives/edgar/data/2102720/000121390026066188/0001213900-26-066188-index.htm) Amendment | 333-295210 | 0001213900-26-066188 |
| 2026-05-18 | [F-1/A](https://www.sec.gov/Archives/edgar/data/2102720/000121390026058235/0001213900-26-058235-index.htm) Amendment | 333-295210 | 0001213900-26-058235 |
| 2026-04-21 | [F-1](https://www.sec.gov/Archives/edgar/data/2102720/000121390026046063/0001213900-26-046063-index.htm) Registration filed | 333-295210 | 0001213900-26-046063 |
| 2025-12-29 | [DRS](https://www.sec.gov/Archives/edgar/data/2102720/000121390025125843/0001213900-25-125843-index.htm) Draft made public | 377-08882 | 0001213900-25-125843 |

[All filings of this company](https://equitycapital.markets/filings?cik=2102720) · [CSV](https://equitycapital.markets/filings.csv?cik=2102720)

---
Source page: https://equitycapital.markets/company/2102720 · Data: U.S. SEC EDGAR · CC BY 4.0
